SCM
NEO icon

Segantii Capital Management’s NeoGenomics NEO Stock Holding History

Segantii Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200,000
Closed -$2.52M – 94
2018
Q4 		$2.52M Buy
+200,000
New +$2.98M 0.21% 24

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Segantii Capital Management's NEO Position: Q1 2019 in Review

Segantii Capital Management sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 200,000 shares — an estimated $2.52M sold.

Segantii Capital Management first reported a position in NEO in Q4 2018 and held it in 1 quarter. The position peaked at $2.52M in Q4 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • Segantii Capital Management reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
  • Segantii Capital Management sold 200,000 NeoGenomics shares in Q1 2019, an estimated $2.52M.
  • Segantii Capital Management first reported a position in NeoGenomics in Q4 2018 and held it in 1 quarter.
  • Segantii Capital Management's NeoGenomics position peaked at $2.52M in Q4 2018.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Segantii Capital Management's 13F filing for Q1 2019, filed 4 Apr 2019.